<scp>HER2</scp> overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the <scp>QUASAR</scp>, <scp>FOCUS</scp> and <scp>PICCOLO</scp> colorectal cancer trialsSusan D. Richman, Philip Quirke, Jennifer H. Barrett et al.|The Journal of Pathology|2015Cited by 238
Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCTPeter J. Selby, Naeem Soomro, Rosamonde E. Banks et al.|Programme Grants for Applied Research|2018Cited by 12